ACT AlzChem Group

EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 5th Interim Report

EQS-News: Alzchem Group AG / Key word(s): Share Buyback/Share Buyback
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 5th Interim Report

20.01.2025 / 10:31 CET/CEST
The issuer is solely responsible for the content of this announcement.


Disclosure according to Article 5 of the EU Regulation 596/2014 and

Article 2 Section (1) of the Delegated EU Regulation 2016/1052

 

 

Trostberg, January 20th, 2025

 

 

5th Interim Report

 

In the period from January 13th up to and including January 17th, 2025, a total of 2,348 shares of Alzchem Group AG were acquired as part of the share buyback programme announced on November 29th, 2024. The total number of shares acquired to date as part of this buyback amounts to 33,003. The acquisition was carried out by a financial institution via the stock exchange (XETRA) on behalf of Alzchem Group AG.

 

The total number of repurchased shares, the weighted average price and the aggregated volume (excl. acquisition costs) per day were as follows:

 

Buyback date Total number of shares Weighted average price (EUR) Aggregated volume (EUR)
2025-01-17 2,348 62.6645 147,136.20
Σ 2,348 62.6645 147,136.20

 

This information as well as the detailed information on the individual daily transactions related to the buy-back programme are also published on the Company's website at in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052.

 

 

Alzchem Group AG

- Managing Board -



20.01.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone:
Fax:
E-mail:
Internet:
ISIN: DE000A2YNT30
WKN: A2YNT3
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 2070917

 
End of News EQS News Service

2070917  20.01.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2070917&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
20/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AlzChem Group

 PRESS RELEASE

EQS-News: Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung...

EQS-News: Alzchem Group AG / Schlagwort(e): Aktienrückkauf/Aktienrückkauf Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 - Zeitweilige Unterbrechung des Aktienrückkaufprogramms 17.03.2025 / 11:38 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Alzchem Group AG   Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052       Trostberg, 17. März 2025   Zeitweilige Unterbrechung de...

 PRESS RELEASE

EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the ...

EQS-News: Alzchem Group AG / Key word(s): Share Buyback/Share Buyback Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Temporary Interruption of Share Repurchase Prog 17.03.2025 / 11:38 CET/CEST The issuer is solely responsible for the content of this announcement. Alzchem Group AG   Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052     Trostberg, March 17, 2025   Temporary Inter...

Peter Thilo Hasler
  • Peter Thilo Hasler

Von hohem Niveau aus weiter aufwärts

Dass Alzchem auch im vierten Quartal 2024 sowohl die eigene Guidance als auch alle Consensus-Prognosen übertraf, kann aus unserer Sicht nicht als Normalität eingestuft werden. Kritisch ließe sich einwenden, dass die Luft angesichts des inzwischen erreichten Margenniveaus dünner wird, doch lässt die anhaltende Verschiebung zum höhermargigen Segment Specialty Chemicals nach unserer Auffassung einen erneuten Margenanstieg und einen damit einhergehenden überproportionalen Ergebnisanstieg auch im Ges...

 PRESS RELEASE

EQS-News: Alzchem Group AG achieves record EBITDA of EUR 105.3 million...

EQS-News: Alzchem Group AG / Key word(s): Annual Results/Annual Report Alzchem Group AG achieves record EBITDA of EUR 105.3 million (+29.4%) in fiscal year 2024 28.02.2025 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. Alzchem Group AG achieves record EBITDA of EUR 105.3 million (+29.4%) in fiscal year 2024 Free cash flow climbs significantly by 42.3% to EUR 74.2 million Dividend to be increased by 50% from EUR 1.20 to EUR 1.80 Further sales and EBITDA growth forecast for 2025 Trostberg, February 28, 2025 – Alzchem Group AG, a ...

 PRESS RELEASE

EQS-News: Alzchem Group AG erzielt im Geschäftsjahr 2024 ein Rekord-EB...

EQS-News: Alzchem Group AG / Schlagwort(e): Jahresergebnis/Jahresbericht Alzchem Group AG erzielt im Geschäftsjahr 2024 ein Rekord-EBITDA in Höhe von 105,3 Mio. Euro (+29,4 %) 28.02.2025 / 06:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Alzchem Group AG erzielt im Geschäftsjahr 2024 ein Rekord-EBITDA in Höhe von 105,3 Mio. Euro (+29,4 %) Free-Cashflow klettert deutlich um 42,3 % auf 74,2 Mio. Euro Dividende soll um 50 % von 1,20 Euro auf 1,80 Euro erhöht werden Weiteres Umsatz- und EBITDA-Wachstum für 2025 prognostiziert Tro...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch